These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20697760)

  • 21. 1-(Piperidin-3-yl)thymine amides as inhibitors of
    Jian Y; Risseeuw MDP; Froeyen M; Song L; Cappoen D; Cos P; Munier-Lehmann H; van Calenbergh S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1730-1739. PubMed ID: 31822127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase.
    Van Calenbergh S; Pochet S; Munier-Lehmann H
    Curr Top Med Chem; 2012; 12(7):694-705. PubMed ID: 22283813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: a docking and molecular dynamics study.
    Chaitanya M; Babajan B; Anuradha CM; Naveen M; Rajasekhar C; Madhusudana P; Kumar CS
    J Mol Model; 2010 Aug; 16(8):1357-67. PubMed ID: 20140471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents.
    Jian Y; Hulpia F; Risseeuw MDP; Forbes HE; Munier-Lehmann H; Caljon G; Boshoff HIM; Van Calenbergh S
    Eur J Med Chem; 2020 Sep; 201():112450. PubMed ID: 32623208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans.
    Pochet S; Dugué L; Labesse G; Delepierre M; Munier-Lehmann H
    Chembiochem; 2003 Aug; 4(8):742-7. PubMed ID: 12898625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenging the Biginelli scaffold to surpass the first line antitubercular drugs:
    El-Shoukrofy MS; Atta A; Fahmy S; Sriram D; Shehat MG; Labouta IM; Mahran MA
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2386668. PubMed ID: 39258667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase.
    Van Daele I; Munier-Lehmann H; Hendrickx PM; Marchal G; Chavarot P; Froeyen M; Qing L; Martins JC; Van Calenbergh S
    ChemMedChem; 2006 Oct; 1(10):1081-90. PubMed ID: 16921580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium tuberculosis thymidylate kinase: structural studies of intermediates along the reaction pathway.
    Fioravanti E; Haouz A; Ursby T; Munier-Lehmann H; Delarue M; Bourgeois D
    J Mol Biol; 2003 Apr; 327(5):1077-92. PubMed ID: 12662932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of mycobacterial Thymidylate kinase inhibitors: a comprehensive pharmacophore, machine learning, molecular docking, and molecular dynamics simulation studies.
    Chikhale RV; Pawar SP; Kolpe MS; Shinde OD; Dahlous KA; Mohammad S; Patil PC; Bhowmick S
    Mol Divers; 2024 Aug; 28(4):1947-1964. PubMed ID: 39152354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library.
    Koseki Y; Kinjo T; Kobayashi M; Aoki S
    Eur J Med Chem; 2013 Feb; 60():333-9. PubMed ID: 23314046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
    Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Van Calenbergh S
    Verh K Acad Geneeskd Belg; 2006; 68(4):223-48. PubMed ID: 17214439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of 5'-modified thymidines and 5-hydroxymethyl-2'-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors.
    Toti KS; Verbeke F; Risseeuw MD; Frecer V; Munier-Lehmann H; Van Calenbergh S
    Bioorg Med Chem; 2013 Jan; 21(1):257-68. PubMed ID: 23199481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular modeling studies of Fatty acyl-CoA synthetase (FadD13) from Mycobacterium tuberculosis--a potential target for the development of antitubercular drugs.
    Jatana N; Jangid S; Khare G; Tyagi AK; Latha N
    J Mol Model; 2011 Feb; 17(2):301-13. PubMed ID: 20454815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques.
    Kumar V; Saravanan P; Arvind A; Mohan CG
    J Mol Model; 2011 May; 17(5):939-53. PubMed ID: 20614148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors.
    Song L; Merceron R; Hulpia F; Lucía A; Gracia B; Jian Y; Risseeuw MDP; Verstraelen T; Cos P; Aínsa JA; Boshoff HI; Munier-Lehmann H; Savvides SN; Van Calenbergh S
    Eur J Med Chem; 2021 Dec; 225():113784. PubMed ID: 34450493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine learning-based drug design for identification of thymidylate kinase inhibitors as a potential anti-Mycobacterium tuberculosis.
    Shahab M; Danial M; Duan X; Khan T; Liang C; Gao H; Chen M; Wang D; Zheng G
    J Biomol Struct Dyn; 2024 May; 42(8):3874-3886. PubMed ID: 37232453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endeavors towards transformation of M. tuberculosis thymidylate kinase (MtbTMPK) inhibitors into potential antimycobacterial agents.
    Jian Y; Merceron R; De Munck S; Forbes HE; Hulpia F; Risseeuw MDP; Van Hecke K; Savvides SN; Munier-Lehmann H; Boshoff HIM; Van Calenbergh S
    Eur J Med Chem; 2020 Nov; 206():112659. PubMed ID: 32823003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinases as antituberculosis targets: The case of thymidylate kinases.
    Sukumar S; Krishman A; Khan MKA
    Front Biosci (Landmark Ed); 2020 Mar; 25(9):1636-1654. PubMed ID: 32114448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.